Post-effective amendment to a registration statement that is not immediately effective upon filing

Earnings (Loss) per Share (Tables)

v3.22.2.2
Earnings (Loss) per Share (Tables)
6 Months Ended 11 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 02, 2021
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Schedule of computation of basic net loss per share  

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

For the Period from

 

For the Period from January 1,

 

August 20, 2020 (Inception)

 

2021 through

 

through

 

December 2, 2021

 

December 31, 2020

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net loss per common stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Allocation of net loss, as adjusted

$

(24,805,124)

$

$

$

(2,286)

Denominator:

 

  

 

  

 

  

 

  

Basic and diluted weighted average stock outstanding

 

29,692,013

 

 

 

6,875,000

Basic and diluted net loss per common stock

$

(0.84)

$

$

$

(0.00)

 
P3 Health Partners Inc.      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Schedule of computation of basic net loss per share

    

Successor

Three Months
Ended June 30, 

    

Six Months
Ended June 30, 

2022

2022

Numerator - Basic:

Net loss

$

(903,105,939)

 

$

(963,896,193)

Less: Net loss attributable to Non-controlling interest

 

(748,755,990)

(798,968,740)

Net loss attributable to Class A common stockholders - Basic

 

(154,349,949)

(164,927,453)

Numerator - Diluted:

Net loss attributable to Class A common stockholders - Basic

$

(154,349,949)

$

(164,927,453)

Add: Net loss and tax effect attributable to Non-controlling interest

(748,755,990)

(798,968,740)

Net loss attributable to Class A common stockholders - Diluted

(903,105,939)

(963,896,193)

Denominator - Basic:

Weighted average Class A common shares outstanding - Basic

 

41,578,890

41,578,890

Loss per share attributable to Class A common shareholders - Basic

 

$

(3.71)

$

(3.97)

Denominator - Diluted:

Weighted average Class A common shares outstanding - Basic

41,578,890

41,578,890

Weighted average effect of dilutive Class V shares

200,473,866

198,782,864

Weighted average Class A common shares outstanding - Diluted

242,052,756

240,361,754

Loss per share attributable to Class A common shareholders - Diluted

$

(3.73)

$

(4.01)

 

Successor

December 3, 2021

through December 31,

    

2021

Net Loss

$

(57,937,929)

Loss Attributable to Non-controlling Interest

 

(47,856,729)

Net Loss Attributable to Class A Common Stockholders - Basic and Diluted EPS

$

(10,081,200)

Weighted Average Class A Common Shares Outstanding - Basic and Diluted EPS

41,578,890

Loss per Share Attributable to Class A Common Shareholders - Basic and Diluted

$

(0.24)

Schedule of potential dilutive securities excluded from the computation of diluted net loss per share their effect would have been anti-dilutive

    

Successor

As of June 30, 2022

Public Warrants

 

10,591,605

Private Warrants

 

227,500

Restricted Shares

 

601,614

Options

 

2,134,279

 

13,554,998

 

Successor

December 3, 2021

through December 31,

    

2021

Public Warrants

10,541,667

Private Warrants

277,500

Restricted Shares

5,471,400

Total

16,290,567